Gustavo De La Cruz ReynozoAssociateK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmail617-951-9041 Professional Biography Gustavo De La Cruz Reynozo is an associate in the firm’s Boston office. He is a member of the Asset Management and Investment Funds practice group. More Legal and Business Bylines From Gustavo De La Cruz Reynozo Checked Swing—SEC Does Not Adopt "Swing Pricing" or a "Hard Close" for Now, but Only Provides Liquidity Guidance and Amendments to Forms N-Port and N-Cen - (Posted On Wednesday, September 11, 2024) United States: CFTC Proposes to Broaden Scope of Eligible Collateral for Initial Margin - (Posted On Friday, July 28, 2023) The SEC Significantly Expands the Scope of Form PF Reporting - (Posted On Saturday, May 13, 2023) United States: SEC Adopts Amendments to Form PF and Significantly Expands Reporting Requirements - (Posted On Thursday, May 04, 2023) United States: SEC Proposes Amendments to Broaden the Scope of Regulation S-P in Response to Digital Communications and Risks to Customer Personal Information - (Posted On Friday, March 17, 2023) Current Legal Analysis DOE Releases SAF Grand Challenge Roadmap Implementation Framework by: Lynn L. Bergeson , Carla N. Hutton California DFPI Poised to Fill Potential Regulatory Gap Amid Anticipated CFPB Leadership Shift by: A.J. S. Dhaliwal , Mehul N. Madia FDA Extends Comment Deadline for Proposed Post-Market Assessment Approach by: Food and Drug Law at Keller and Heckman Understanding French Export and Re-Export Prohibitions: Ministry of Armed Forces Releases FAQ on Non Re-Exportation Certificates by: Sabine Naugès , Michal Chajdukowski New CFPB Larger Participant Rule Boosts Oversight of Major Digital Payment Providers by: A.J. S. Dhaliwal , Mehul N. Madia California Poised to Fill Potential Regulatory Gap Amid Anticipated CFPB Leadership Shift by: A.J. S. Dhaliwal , Mehul N. Madia Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 REACH 30/30 - 04 December 2024 Dec 5 2024 Home Care Industry Update Dec 5 2024 Annual Review: Non-compete and Trade Secret Protection for Employers Dec 11 2024 2025 Annual Reporting & Proxy Season Update Print
